LRG1 as a novel therapeutic target in eye disease. (2022)
Attributed to:
Leucine-rich alpha-2-glycoprotein 1 (Lrg1) as a novel modulator of TGFbeta signalling in disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41433-021-01807-4
PubMed Identifier: 34987199
Publication URI: http://europepmc.org/abstract/MED/34987199
Type: Journal Article/Review
Volume: 36
Parent Publication: Eye (London, England)
Issue: 2
ISSN: 0950-222X